Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Srijit Paul

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Physical Review Letters|May 9, 2025
B→ρℓν[over ¯] Resonance Form Factors from B→ππℓν[over ¯] in Lattice QCDLuka Leskovec, Stefan Meinel, Marcus Petschlies, et al.
Leukemia Research Reports|March 30, 2026
T-cell receptor anti-CMV CDR3s from bone marrow samples are associated with a worse overall survival for recurrent acute myeloid leukemiaSrijit Paul, Michael T Aboujaoude, Vayda R Barker, et al.
Cureus|March 7, 2025
Navigating Cytomegalovirus Retinitis in a Patient With Myelodysplastic Syndromes Transitioning to Acute Myeloid Leukemia Post Transplant: A Case StudySteven A Benyahia, Sunny Kahlon, Srijit Paul, et al.
International Journal of Cancer|October 8, 2024
Detection of anti-EBV TCR CDR3s associated with better outcomes for EBV-positive, Ugandan cases of Burkitt lymphomaRahul Jain, Taha I Huda, Srijit Paul, et al.
Human Immunology|December 16, 2025
Better pancreatic adenocarcinoma outcomes linked to anti-EBV TCR CDR3 detection via tumor RNAseq filesMadeline C Baker, Srijit Paul, Genesis V Lewis, et al.
Anticancer Research|March 27, 2024
TCR CDR3-CMV Antigen Chemical Complementaries Are Associated With a Worse Outcome for Renal Cell CarcinomaLila Alkassab, Michael J Diaz, Elizabeth A Fletcher, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Physical Review Letters|May 9, 2025
B→ρℓν[over ¯] Resonance Form Factors from B→ππℓν[over ¯] in Lattice QCDLuka Leskovec, Stefan Meinel, Marcus Petschlies, et al.
Leukemia Research Reports|March 30, 2026
T-cell receptor anti-CMV CDR3s from bone marrow samples are associated with a worse overall survival for recurrent acute myeloid leukemiaSrijit Paul, Michael T Aboujaoude, Vayda R Barker, et al.
Cureus|March 7, 2025
Navigating Cytomegalovirus Retinitis in a Patient With Myelodysplastic Syndromes Transitioning to Acute Myeloid Leukemia Post Transplant: A Case StudySteven A Benyahia, Sunny Kahlon, Srijit Paul, et al.
International Journal of Cancer|October 8, 2024
Detection of anti-EBV TCR CDR3s associated with better outcomes for EBV-positive, Ugandan cases of Burkitt lymphomaRahul Jain, Taha I Huda, Srijit Paul, et al.
Human Immunology|December 16, 2025
Better pancreatic adenocarcinoma outcomes linked to anti-EBV TCR CDR3 detection via tumor RNAseq filesMadeline C Baker, Srijit Paul, Genesis V Lewis, et al.
Anticancer Research|March 27, 2024
TCR CDR3-CMV Antigen Chemical Complementaries Are Associated With a Worse Outcome for Renal Cell CarcinomaLila Alkassab, Michael J Diaz, Elizabeth A Fletcher, et al.
Pageof 1